Barclays PLC
Search documents
Barclays PLC增持龙蟠科技(02465)931.6万股 每股作价约8.35港元
智通财经网· 2025-08-15 11:08
智通财经APP获悉,香港联交所最新数据显示,8月11日,Barclays PLC增持龙蟠科技(02465)931.6万 股,每股作价8.3525港元,总金额约为7781.19万港元。增持后最新持股数目为1113.1万股,持股比例为 9.28%。 ...
Barclays PLC增持天齐锂业(09696)316.56万股 每股作价约47.31港元
智通财经网· 2025-08-15 11:08
Group 1 - Barclays PLC increased its stake in Tianqi Lithium Corporation (09696) by 3.1656 million shares at a price of HKD 47.3146 per share, totaling approximately HKD 150 million [1] - After the increase, Barclays' total shareholding in Tianqi Lithium is now 8.3289 million shares, representing a holding percentage of 5.07% [1]
Barclays PLC增持龙蟠科技931.6万股 每股作价约8.35港元
Zhi Tong Cai Jing· 2025-08-15 11:05
Group 1 - Barclays PLC increased its stake in Longpan Technology (603906) (02465) by acquiring 9.316 million shares at a price of 8.3525 HKD per share, totaling approximately 77.81 million HKD [1] - After the acquisition, Barclays PLC's total shareholding in Longpan Technology reached 11.131 million shares, representing a holding percentage of 9.28% [1]
Barclays PLC增持天齐锂业316.56万股 每股作价约47.31港元
Zhi Tong Cai Jing· 2025-08-15 11:05
Core Insights - Barclays PLC increased its stake in Tianqi Lithium Corporation (002466)(09696) by acquiring 3.1656 million shares at a price of HKD 47.3146 per share, totaling approximately HKD 150 million [1] - Following this acquisition, Barclays' total shareholding in Tianqi Lithium reached 8.3289 million shares, representing a 5.07% ownership stake [1]
Skydance Media Announces Full Slate of Board Designees for Paramount
GlobeNewswire News Room· 2025-08-05 13:00
Future directors comprise world-renowned, accomplished leaders from media, technology, and global business LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Skydance Media today announced the full slate of director designees for Paramount Skydance Corporation ("Paramount"). The directors will be elected and begin serving on the Paramount Board effective at the closing of the proposed merger with Paramount Global (NASDAQ: PARA, PARAA). The Paramount Board will consist of 10 directors, including three independen ...
中国中免(01880.HK)获Barclays PLC增持459.09万股


Ge Long Hui· 2025-07-30 23:34
| 表格序號 | 大股東/董事/最高行政人員名稱作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | 持有權益的股份數目 佔已發行的 有關事件的日期 | | | --- | --- | --- | --- | --- | --- | | | 股份數目 | 原因 | | (請參閱上述 * 註 | 有投票權股 (日 / 月 / 年) | | | | | | 能 | 份百分比 | | | | | | | ( % ) | | CS20250729E00552 | HKD 63.0819 Barclays PLC | 1001(L) | 4.590.900(L) | 6.126.400(L | 5.26(L)24/07/2025 | | | | 14015(S) | 929.600(S) | 2.283.700(S) | 1.96(S) | | 股份代號: | 01880 | | --- | --- | | 上市法國名稱: | 中國旅遊集團中免股份有限公司 - H | | 日期 (日 / 月 / 年): | 30/06/2025 - 31/07/2025 | 格隆汇7月31日丨根据联交所最新权益披露资料显示,2 ...
Barclays PLC增持中国中免(01880)459.09万股 每股作价约63.08港元
智通财经网· 2025-07-30 11:19
智通财经APP获悉,香港联交所最新数据显示,7月24日,Barclays PLC增持中国中免(01880)459.09万 股,每股作价63.0819港元,总金额约为2.90亿港元。增持后最新持股数目为612.64万股,持股比例为 5.26%。 ...
Barclays PLC增持中国中免459.09万股 每股作价约63.08港元
Zhi Tong Cai Jing· 2025-07-30 11:17
香港联交所最新数据显示,7月24日,Barclays PLC增持中国中免(601888)(01880)459.09万股,每股作 价63.0819港元,总金额约为2.90亿港元。增持后最新持股数目为612.64万股,持股比例为5.26%。 ...
这家券商遭易方达、巴克莱抢筹!均到举牌线
券商中国· 2025-07-19 05:16
H股的中原证券竟遭遇两大机构抢筹。 中原证券是河南省内规模最大券商,今年上半年,中原证券刚完成换帅。对于新任董事长而言,找到业务突破方向,带领中原证券"二次创业"、扭转业绩下滑成为 重要目标。今年一季度,中原证券营业收入为4.01亿元,同比下降37.7%;归母净利润为1.03亿元,同比下降21.3%。截至7月17日,中州证券报2.8港元/股,总市值 130亿港元,A股中原证券报4.39元/股,总市值203.8亿元。 近日,港交所披露,来自河南的中州证券(01375,即中原证券的H股)备受机构青睐,该公司同时被公募巨头易方达基金和英国第三大银行(以资产计)巴克莱银 行(Barclays PLC)举牌,持股比例均超过了5%。 两大顶流机构举牌 还记得7月11日,港股券商集体飙升,中州证券一度暴涨75%吗?这背后的买家浮出水面。 整体而言,巴克莱银行好仓持股远远大于淡仓持股,净好仓持股中州证券1.22亿股,代表看好该公司,持股比例仅次于中州证券大股东河南投资集团有限公司。 与此同时,除了上述英国第三大银行巴克莱银行,公募巨头易方达基金也买成了中州证券持股5%以上大股东。 7月15日港交所披露,易方达基金也在7月11 ...
Barclays Prevails in Two Lawsuits Over $17.7B Securities Overissuance
ZACKS· 2025-03-25 17:46
Core Viewpoint - Barclays PLC successfully dismissed two U.S. securities fraud lawsuits related to the excess debt sale of $17.7 billion beyond regulatory limits, indicating a lack of fraudulent intent and adequate remedial actions taken by the bank [1][4]. Summary by Relevant Sections Lawsuit Details - Investors engaged in short-selling Barclays' iPath Series B S&P 500 VIX Short-Term Futures exchange-traded notes (VXX) claimed monetary losses due to reliance on the bank's assurances regarding internal controls and regulatory compliance [2]. - The lawsuit was triggered by Barclays' failure to comply with regulatory limits and the suspension of VXX issuances in March 2022, which led to a 140% surge in VXX prices over its indicative value [2]. Overissuance and Financial Impact - In March 2022, Barclays acknowledged selling $15.2 billion more structured and exchange-traded notes than the $20.8 billion limit approved by U.S. regulators, which later increased to $17.7 billion [3]. - Barclays set aside £1.59 billion ($2.01 billion) for the overissuance and offered to repurchase the excess amount [3]. Court Ruling and Justifications - The judge ruled that there was no evidence of fraudulent intent by Barclays, stating that bank officials had an incentive to register securities appropriately [4]. - The court found that Barclays' corrective actions, including halting sales and making disclosures, demonstrated good faith rather than deception [5]. Investor Claims and Court Findings - Investor claims of being misled about Barclays' internal controls were rejected, as the court determined that general statements about internal controls were not actionable [6]. Regulatory and Legal Consequences - Barclays paid $361 million in settlement charges to the U.S. Securities and Exchange Commission in September 2022, which included a $200 million fine related to the overissuance [7]. - The company also agreed to a $19.5 million settlement in a separate shareholder lawsuit in December 2022 [7]. Stock Performance - Over the past six months, Barclays shares have increased by 29.5%, outperforming the industry growth of 9.5% [8].